DocDollars

Spark Therapeutics, Inc.

PA · United States · Reporting entity ID 100000226812

Total reported 2019–2025
$29.4M
#245 of 2,960 reporting companies — 0% of all reported industry payments
$15.5M in general payments across 2,859 records, plus $13.9M in research funding across 1,158 records.

How it breaks down

General payments $15,453,874
Research funding $13,948,762

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Spark Therapeutics, Inc. reported $29.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #245 of 2,960 reporting companies. 47% of that was research funding and 53% general payments such as consulting, speaking, food and travel. 2,859 general payment records and 1,158 research records were filed.

Common questions about Spark Therapeutics, Inc.

How much has Spark Therapeutics, Inc. paid US doctors?

Spark Therapeutics, Inc. reported $29,402,636 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $15,453,874 in general payments, $13,948,762 in research funding.

How does Spark Therapeutics, Inc. rank among drug and device companies?

It ranks #245 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Spark Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.